1Equipe 11 Labellisée par la Ligue Nationale Contre le Cancer, Centre de Recherche des Cordeliers, Paris, France
2U1138, INSERM, Paris, France
3Metabolomics and Cell Biology Platforms, Gustave Roussy Campus Cancer, Villejuif, France
4Faculté de Medecine, Université Paris-Sud, Le Kremlin-Bicêtre, France
5Department of Chemistry, University of Coimbra, Coimbra, Portugal
6Laboratory for General Biochemistry and Physical Pharmacy, Faculty of Pharmacy, Ghent University, Ghent, Belgium
7Laboratory of Molecular and Cellular Therapy, Vrije Universiteit Brussel, Jette, Belgium
8Sotio a.c., Prague, Czech Republic
9Department of Immunology, 2nd Faculty of Medicine, University Hospital Motol, Charles University, Prague, Czech Republic
10Gustave Roussy Campus Cancer, Villejuif, France
11Université Paris Descartes, Paris, France
12Université Pierre et Marie Curie, Paris, France
13Pôle de Biologie, Hopitâl Européen George Pompidou, AP-HP, Paris, France
Edited and reviewed by: Patrizia Agostinis, University of Leuven, Belgium
✉*Correspondence: Oliver Kepp, oliver.kepp@gustaveroussy.fr; Guido Kroemer, kroemer@orange.fr
†Lucillia Bezu and Ligia C. Gomes-da-Silva have contributed equally to this work.
‡Share senior co-authorship.
Specialty section: This article was submitted to Tumor Immunity, a section of the journal Frontiers in Immunology
Copyright © 2015 Bezu, Gomes-da-Silva, Dewitte, Breckpot, Fucikova, Spisek, Galluzzi, Kepp and Kroemer.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.